USB1 deficiency disrupts neutrophil maturation via RNA dysregulation independent of global pre‐ mRNA splicing
Animal Models and Experimental Medicine · Published 2026-04-20 · DOI 10.1002/ame2.70206
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1002/ame2.70206
Abstract
Abstract Background U6 biogenesis 1 (USB1) gene mutations cause poikiloderma with neutropenia (PN), which is clinically characterized by skin hyperpigmentation, nail dysplasia, neutropenia, and an elevated risk of cancer. USB1 functions as an RNA exonuclease involved in RNA maturation and stability regulation, although its precise mechanism of action in the hematopoietic system remains unclear. Methods We established a myeloid cell‐specific USB1 knockout mouse model (USB1fl/fl‐Lyz2‐cre) using CRISPR/Cas9. Using a combination of research methods, including Western blot, flow cytometry, messenger RNA (mRNA) sequencing, microRNA (miRNA) sequencing, and quantitative polymerase chain reaction (qPCR), we investigated the effects of USB1 deficiency on neutrophil development and differentiation, along with the underlying signaling molecular mechanisms. Results Experimental results indicated that USB1 deficiency in mouse myeloid cells not only leads to dysregulation of miRNA expression but also interferes with the developmental, differentiation, and maturation processes of neutrophils by affecting key genes, such as IL1a, Selp, and Kilt. This impact can be traced back to the stages of myeloid progenitor cells. Conclusions USB1 influences neutrophil maturation and myeloid progenitor cell differentiation by regulating the expression of specific miRNAs and mRNAs. This provides novel in vivo experimental evidence for understanding the pathogenesis of PN in patients.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2026
Related articles
- A mouse model of mechanical stress injury to the basal ganglia using thermosensitive PNIPAM hydrogel for intracerebral hemorrhage research · Animal Models and Experimental Medicine · 2026 · Same journal
- Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia–reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics · Animal Models and Experimental Medicine · 2026 · Same journal
- Strategies for inducing diabetes in laboratory animals: Advances from chemical, surgical, immunologic, dietary, and genetic approaches · Animal Models and Experimental Medicine · 2026 · Same journal
- A novel mouse model of chronic Pseudomonas aeruginosa infection inducing bronchiectasis‐like phenotype · Animal Models and Experimental Medicine · 2026 · Same journal
- ApoE ‐ and Cfh‐deficient mice exhibit structural and molecular features of human early–intermediate retinal degeneration · Animal Models and Experimental Medicine · 2026 · Same journal
- Stem cell–based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection · Animal Models and Experimental Medicine · 2026 · Same journal
- Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats · Animal Models and Experimental Medicine · 2026 · Same journal
- Chronic alcohol consumption compromises gut barrier integrity and promotes endotoxemia: Implications for sepsis susceptibility in immunocompromised hosts · Animal Models and Experimental Medicine · 2026 · Same journal
- Clotrimazole‐loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter · Animal Models and Experimental Medicine · 2026 · Same journal
- Time‐course characterization of intraocular pressure in murine steroid‐induced ocular hypertension: Effects of route, schedule, and concentration · Animal Models and Experimental Medicine · 2026 · Same journal